The publisher and editorial staff of The ASCO Post are happy to share an exciting announcement. While our company was formerly known as Harborside, powered by BroadcastMed, earlier this summer we announced a new name and platform for our business, Conexiant. Importantly, we continue our essential partnership with ASCO in the development and publication of The ASCO Post and its programs and products.
Conexiant.com is designed to serve as a resource for clinical connectivity and learning, fostering a unified community that diminishes the divide in accessing interdisciplinary content. This new platform will elevate The ASCO Post into a larger forum for all health-care professionals. The platform will feature specialties outside of oncology including family medicine, cardiology, dermatology, and more. Individuals who visit any of these other health-care web pages will have the opportunity to access ASCOPost.com via the Conexiant
Oncology page.
This new platform complements the strengths of our editorial content and enhances the experience for readers seeking timely, trustworthy clinical news and responsible journalism.
Visit Conexiant.com for more information.
